Caption Management, LLC Lyra Therapeutics, Inc. Transaction History
Caption Management, LLC
- $9.79 Billion
- Q1 2025
A detailed history of Caption Management, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 246,600 shares of LYRA stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246,600Holding current value
$2.22 Million% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
57Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$115 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$25.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$15.9 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$12.5 Million0.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$9.52 Million0.02% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $286M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...